Showing results (41-50 of 183) with videos related to
Sort By:
Pageof 19
Clinical Pharmacokinetics|July 1, 1988
Pharmacokinetics of calcium antagonists under developmentD R Abernethy, J B SchwartzClinical Pharmacology and Therapeutics|April 15, 2011
Pharmacological mechanism-based drug safety assessment and predictionD R Abernethy, J Woodcock, L J LeskoClinical Pharmacology and Therapeutics|December 29, 1999
Ticlopidine inhibits phenytoin clearanceS Donahue, D A Flockhart, D R AbernethyLife Sciences|January 1, 1996
Endothelin-1 induces an increase in total protein synthesis and expression of the smooth muscle alpha-actin gene in vascular smooth muscle cellsN S Andrawis, E Wang, D R AbernethyClinical Pharmacology and Therapeutics|August 1, 1986
Diltiazem treatment impairs hepatic drug oxidation: studies of antipyrineG Carrum, J M Egan, D R AbernethyInternational Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1983
Kinetics of low-dose intravenous antipyrine: use of liquid chromatographyD J Greenblatt, D R Abernethy, M DivollClinical Pharmacology and Therapeutics|December 1, 1992
Endothelin-I-mediated vasoconstriction: specific blockade by verapamilN S Andrawis, J Gilligan, D R AbernethyClinical Pharmacology and Therapeutics|September 1, 1995
Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistanceD R Abernethy, N Laurie, N S AndrawisJournal of Clinical Pharmacology|August 1, 1983
Is volume of distribution at steady state a meaningful kinetic variable?D J Greenblatt, D R Abernethy, M DivollJournal of Cardiovascular Pharmacology|January 1, 1988
Amlodipine in elderly hypertensive patients: pharmacokinetics and pharmacodynamicsD R Abernethy, J Gutkowska, M D LambertPageof 19